| Dr Nicole Marie Bock, DNP, APN, FNP-C | |
|
975 Nj-73 North, Suite E, Marlton, NJ 08053 | |
| (609) 910-0270 | |
| (609) 380-2935 |
| Full Name | Dr Nicole Marie Bock |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 975 Nj-73 North, Marlton, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376107839 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 26NR18161900 (New Jersey) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 26NJ00927200 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Harkaway Llc | 0941542120 | 5 |
News Archive
"The nation's uninsured — a growing class of people whose recession-fed ranks have swelled to 46.3 million — are central to the health care debate in Washington and the questions about how and whether to get them covered are as vexing and emotional as they come," USA Today reports. "While the nation waits for Congress and the White House to come up with answers, those who live without insurance say they are waiting scared."
Edge Therapeutics announced today positive preliminary results from the first human use of EG-1962, the Company's novel bioabsorbable nimodipine microparticle formulation for the prevention of delayed cerebral ischemia, a life-threatening complication of subarachnoid hemorrhage, typically resulting from a ruptured brain aneurysm or traumatic brain injury.
Roche announced today that it has filed a direct de novo application to the U.S. Food and Drug Administration for a fully automated Anti-Mullerian (AMH) assay for use on Roche's full portfolio of laboratory analyzers. The determination of AMH is useful for the assessment of ovarian reserve in women presenting to infertility clinics for evaluation in conjunction with other clinical and laboratory findings.
Hepatitis C virus is more common in patients with alcoholic hepatitis than the general population, but infections may be going undetected, US data show.
Concuity, a healthcare division of Trintech (Nasdaq: TTPA) and a leading provider of Revenue Cycle Management technology and services, announced the new release of ClearContracts(TM) 9.0. Used by the largest and most sophisticated hospital systems in the U.S., ClearContracts(TM) is a web-based suite of software that enables healthcare providers to meet all of their managed care and revenue recovery goals.
› Verified 9 days ago
| Entity Name | Robert J Maro Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952342743 PECOS PAC ID: 5193627826 Enrollment ID: O20040123000195 |
News Archive
"The nation's uninsured — a growing class of people whose recession-fed ranks have swelled to 46.3 million — are central to the health care debate in Washington and the questions about how and whether to get them covered are as vexing and emotional as they come," USA Today reports. "While the nation waits for Congress and the White House to come up with answers, those who live without insurance say they are waiting scared."
Edge Therapeutics announced today positive preliminary results from the first human use of EG-1962, the Company's novel bioabsorbable nimodipine microparticle formulation for the prevention of delayed cerebral ischemia, a life-threatening complication of subarachnoid hemorrhage, typically resulting from a ruptured brain aneurysm or traumatic brain injury.
Roche announced today that it has filed a direct de novo application to the U.S. Food and Drug Administration for a fully automated Anti-Mullerian (AMH) assay for use on Roche's full portfolio of laboratory analyzers. The determination of AMH is useful for the assessment of ovarian reserve in women presenting to infertility clinics for evaluation in conjunction with other clinical and laboratory findings.
Hepatitis C virus is more common in patients with alcoholic hepatitis than the general population, but infections may be going undetected, US data show.
Concuity, a healthcare division of Trintech (Nasdaq: TTPA) and a leading provider of Revenue Cycle Management technology and services, announced the new release of ClearContracts(TM) 9.0. Used by the largest and most sophisticated hospital systems in the U.S., ClearContracts(TM) is a web-based suite of software that enables healthcare providers to meet all of their managed care and revenue recovery goals.
› Verified 9 days ago
| Entity Name | Clare Medical Of New Jersey, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255718276 PECOS PAC ID: 8325369895 Enrollment ID: O20150609001994 |
News Archive
"The nation's uninsured — a growing class of people whose recession-fed ranks have swelled to 46.3 million — are central to the health care debate in Washington and the questions about how and whether to get them covered are as vexing and emotional as they come," USA Today reports. "While the nation waits for Congress and the White House to come up with answers, those who live without insurance say they are waiting scared."
Edge Therapeutics announced today positive preliminary results from the first human use of EG-1962, the Company's novel bioabsorbable nimodipine microparticle formulation for the prevention of delayed cerebral ischemia, a life-threatening complication of subarachnoid hemorrhage, typically resulting from a ruptured brain aneurysm or traumatic brain injury.
Roche announced today that it has filed a direct de novo application to the U.S. Food and Drug Administration for a fully automated Anti-Mullerian (AMH) assay for use on Roche's full portfolio of laboratory analyzers. The determination of AMH is useful for the assessment of ovarian reserve in women presenting to infertility clinics for evaluation in conjunction with other clinical and laboratory findings.
Hepatitis C virus is more common in patients with alcoholic hepatitis than the general population, but infections may be going undetected, US data show.
Concuity, a healthcare division of Trintech (Nasdaq: TTPA) and a leading provider of Revenue Cycle Management technology and services, announced the new release of ClearContracts(TM) 9.0. Used by the largest and most sophisticated hospital systems in the U.S., ClearContracts(TM) is a web-based suite of software that enables healthcare providers to meet all of their managed care and revenue recovery goals.
› Verified 9 days ago
| Entity Name | Harkaway Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447717962 PECOS PAC ID: 0941542120 Enrollment ID: O20190509000452 |
News Archive
"The nation's uninsured — a growing class of people whose recession-fed ranks have swelled to 46.3 million — are central to the health care debate in Washington and the questions about how and whether to get them covered are as vexing and emotional as they come," USA Today reports. "While the nation waits for Congress and the White House to come up with answers, those who live without insurance say they are waiting scared."
Edge Therapeutics announced today positive preliminary results from the first human use of EG-1962, the Company's novel bioabsorbable nimodipine microparticle formulation for the prevention of delayed cerebral ischemia, a life-threatening complication of subarachnoid hemorrhage, typically resulting from a ruptured brain aneurysm or traumatic brain injury.
Roche announced today that it has filed a direct de novo application to the U.S. Food and Drug Administration for a fully automated Anti-Mullerian (AMH) assay for use on Roche's full portfolio of laboratory analyzers. The determination of AMH is useful for the assessment of ovarian reserve in women presenting to infertility clinics for evaluation in conjunction with other clinical and laboratory findings.
Hepatitis C virus is more common in patients with alcoholic hepatitis than the general population, but infections may be going undetected, US data show.
Concuity, a healthcare division of Trintech (Nasdaq: TTPA) and a leading provider of Revenue Cycle Management technology and services, announced the new release of ClearContracts(TM) 9.0. Used by the largest and most sophisticated hospital systems in the U.S., ClearContracts(TM) is a web-based suite of software that enables healthcare providers to meet all of their managed care and revenue recovery goals.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nicole Marie Bock, DNP, APN, FNP-C 975 Nj-73 North, Suite E, Marlton, NJ 08053 Ph: (609) 910-0270 | Dr Nicole Marie Bock, DNP, APN, FNP-C 975 Nj-73 North, Suite E, Marlton, NJ 08053 Ph: (609) 910-0270 |
News Archive
"The nation's uninsured — a growing class of people whose recession-fed ranks have swelled to 46.3 million — are central to the health care debate in Washington and the questions about how and whether to get them covered are as vexing and emotional as they come," USA Today reports. "While the nation waits for Congress and the White House to come up with answers, those who live without insurance say they are waiting scared."
Edge Therapeutics announced today positive preliminary results from the first human use of EG-1962, the Company's novel bioabsorbable nimodipine microparticle formulation for the prevention of delayed cerebral ischemia, a life-threatening complication of subarachnoid hemorrhage, typically resulting from a ruptured brain aneurysm or traumatic brain injury.
Roche announced today that it has filed a direct de novo application to the U.S. Food and Drug Administration for a fully automated Anti-Mullerian (AMH) assay for use on Roche's full portfolio of laboratory analyzers. The determination of AMH is useful for the assessment of ovarian reserve in women presenting to infertility clinics for evaluation in conjunction with other clinical and laboratory findings.
Hepatitis C virus is more common in patients with alcoholic hepatitis than the general population, but infections may be going undetected, US data show.
Concuity, a healthcare division of Trintech (Nasdaq: TTPA) and a leading provider of Revenue Cycle Management technology and services, announced the new release of ClearContracts(TM) 9.0. Used by the largest and most sophisticated hospital systems in the U.S., ClearContracts(TM) is a web-based suite of software that enables healthcare providers to meet all of their managed care and revenue recovery goals.
› Verified 9 days ago
Jacquelyn Regina Zagone, PMHNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 777 Route 70 E Ste G101, Marlton, NJ 08053 Phone: 800-413-8020 | |
Dorothy Westlake, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1001 Rt. 73 North, Upper Level A & Main Level, Marlton, NJ 08053 Phone: 856-988-3444 | |
Phenita Sammantha Mouzon, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 777 Route 70 E Ste G101, Marlton, NJ 08053 Phone: 856-818-4020 | |
Mrs. Lisa Spurlock Abrams, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 765 E Route 70, Building A, Marlton, NJ 08053 Phone: 856-797-4721 | |
Rafia Nicola Grooms, DNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 765 Route 70 E Bldg A100, Marlton, NJ 08053 Phone: 856-797-4721 Fax: 856-797-4785 | |
Mrs. Yingqiao Chen, PMHNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2003 Lincoln Dr W Ste B, Marlton, NJ 08053 Phone: 856-886-8839 Fax: 856-210-1874 | |
Ms. Fleurdeliz Alabanzas Germodo, N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 141 Route 70 E Ste B, Marlton, NJ 08053 Phone: 856-596-9057 |